Search Results - "Olmedo, M. E."

Antitumor activity of lurbinectedin (PM01183) and doxorubicin in relapsed small-cell lung cancer: results from a phase I study by Calvo, E., Moreno, V., Flynn, M., Holgado, E., Olmedo, M.E., Lopez Criado, M.P., Kahatt, C., Lopez-Vilariño, J.A., Siguero, M., Fernandez-Teruel, C., Cullell-Young, M., Soto Matos-Pita, A., Forster, M.

“…Lurbinectedin (PM01183) has synergistic antitumor activity when combined with doxorubicin in mice with xenografted tumors. This phase I trial determined the…”
Get full text

SEOM clinical guidelines for the treatment of small-cell lung cancer (SCLC) (2019) by Dómine, M., Moran, T., Isla, D., Martí, J. L., Sullivan, I., Provencio, M., Olmedo, M. E., Ponce, S., Blasco, A., Cobo, M.

“…Small-cell lung cancer (SCLC) accounts for 15% of lung cancers. Only one-third of patients are diagnosed at limited stage. The median survival remains to be…”
Get full text

Sarcoidosis-like reactions in cancer patients treated with immune checkpoint inhibitors: experience in a Spanish hospital by Torres-Jiménez, J., Esteban-Villarrubia, J., García-Abellás, P., Cortés-Salgado, A., Soria-Rivas, A., Gajate-Borau, P., Olmedo-García, M. E., Corral-de la Fuente, E., Lage-Alfranca, Y., Gómez-Rueda, A., Benito-Berlinches, A., Gorospe-Sarasua, L., Garrido-López, P.

“…Background Immune checkpoint inhibitors (ICI) have been associated with several immune-related adverse events, including sarcoidosis-like reactions (SLR). SLR,…”
Get full text

Association of immune-related adverse events (irAEs) and immunotherapy (IT) benefit in advanced non-small cell lung cancer (NSCLC) by Saavedra Serrano, C., Barquín García, A., Corral de la Fuente, E., Serrano Domingo, J.J., Albarrán Artahona, V., Martin Huertas, R., Gómez Rueda, A., Olmedo García, M.E.

Get full text

Benefit of immunotherapy (IT) in advanced non-small cell lung cancer (NSCLC) in elderly patients (EP) by Corral de la Fuente, E., Barquín García, A., Saavedra Serrano, C., Olmedo García, M.E., Martin Huertas, R., Serrano Domingo, J.J., Albarrán Artahona, V., Gómez Rueda, A.

Get full text

1262P - Predictive model for survival in advanced non-small cell lung cancer (NSCLC) treated with frontline pembrolizumab by Rubio, X Mielgo, Garcia, M E Olmedo, Moyano, M Sereno, Aguado, C., Núñez, J.A., Gomez, M Domine, Peña, A M Sánchez, Ariza, I Nalda, Gonzalez, S Cerezo, Cabellos, R Alvarez, Gutiérrez, L Cabezón, Mendez, C Pangua, Cervera, R., Blanco, A Calles, Castro, R López, Torres, J M Sanchez, Martin, A Lopez, Ordonez, A Velastegui, Fernández, E Pérez, Cruz, P.

“…Pembrolizumab monotherapy improved overall survival (OS), progression free survival (PFS) and response rate compared to chemotherapy in patients with…”
Get full text

Predictive model for survival in advanced non-small cell lung cancer (NSCLC) treated with frontline pembrolizumab by Rubio, X Mielgo, Garcia, M E Olmedo, Moyano, M Sereno, Aguado, C., Núñez, J.A., Gomez, M Domine, Peña, A M Sánchez, Ariza, I Nalda, Gonzalez, S Cerezo, Cabellos, R Alvarez, Gutiérrez, L Cabezón, Mendez, C Pangua, Cervera, R., Blanco, A Calles, Castro, R López, Torres, J M Sanchez, Martin, A Lopez, Ordonez, A Velastegui, Fernández, E Pérez, Cruz, P.

Get full text

1262PPredictive model for survival in advanced non-small cell lung cancer (NSCLC) treated with frontline pembrolizumab by Rubio, X Mielgo, Garcia, M E Olmedo, Moyano, M Sereno, Aguado, C, Núñez, J A, Gomez, M Domine, Peña, A M Sánchez, Ariza, I Nalda, Gonzalez, S Cerezo, Cabellos, R Alvarez, Gutiérrez, L Cabezón, Mendez, C Pangua, Cervera, R, Blanco, A Calles, Castro, R López, Torres, J M Sanchez, Martin, A Lopez, Ordonez, A Velastegui, Fernández, E Pérez, Cruz, P

“…Abstract Background Pembrolizumab monotherapy improved overall survival (OS), progression free survival (PFS) and response rate compared to chemotherapy in…”
Get full text

Spontaneous tumor lysis syndrome in the setting of small cell lung cancer: Report of two cases and review of the literature by Martínez-Sáez, O., Mezquita, L., Caravaca-Fontán, F., Reguera, P., Molina, J., Olmedo, M.E., y Garrido, P.

“…Tumor lysis syndrome (TLS) is a life-threatening condition characterized by massive lysis of malignant cells after treatment, which results in hyperuricemia,…”
Get full text

169P_PRBenefit of immunotherapy (IT) in advanced non-small cell lung cancer (NSCLC) in elderly patients (EP) by Corral de la Fuente, E, Barquín García, A, Saavedra Serrano, C, Olmedo García, M E, Martin Huertas, R, Serrano Domingo, J J, Albarrán Artahona, V, Gómez Rueda, A

Get full text

155PAssociation of immune-related adverse events (irAEs) and immunotherapy (IT) benefit in advanced non-small cell lung cancer (NSCLC) by Saavedra Serrano, C, Barquín García, A, Corral de la Fuente, E, Serrano Domingo, J J, Albarrán Artahona, V, Martin Huertas, R, Gómez Rueda, A, Olmedo García, M E

Get full text

Pseudoprogresión en una paciente con adenocarcinoma pulmonar metastásico tratada con nivolumab by Cabañero, Alberto, Gorospe, Luis, Olmedo, Maria Eugenia, Mezquita, Laura

Get full text

Carcinoma broncogénico en paciente con linfangioleiomiomatosis by Gorospe Sarasúa, Luis, Mercedes-Noboa, Edwin, Olmedo-García, María Eugenia

Get full text

Recomendaciones SEPAR de diagnóstico y tratamiento del cáncer de pulmón de células no pequeñas by Álvarez, Felipe Villar, Trueba, Ignacio Muguruza, Sanchis, José Belda, López-Rodó, Laureano Molins, Rodríguez Suárez, Pedro Miguel, de Cos Escuín, Julio Sánchez, Barreiro, Esther, Henar Borrego Pintado, M, Vicente, Carlos Disdier, Aldeyturriaga, Javier Flandes, Gámez García, Pablo, Garrido López, Pilar, León Atance, Pablo, Izquierdo Elena, José Miguel, Novoa Valentín, Nuria M, Rivas de Andrés, Juan José, Crespo, Íñigo Royo, Velázquez, Ángel Salvatierra, Seijo Maceiras, Luis M, Reina, Segismundo Solano, Bujanda, David Aguiar, Ávila Martínez, Régulo J, de Granda Orive, José Ignacio, Martínez, Eva de Higes, Gude, Vicente Díaz-Hellín, Flor, Raúl Embún, Freixinet Gilart, Jorge L, García Jiménez, María Dolores, Alarza, Fátima Hermoso, Sarmiento, Samuel Hernández, Honguero Martínez, Antonio Francisco, Jiménez Ruiz, Carlos A, Sanz, Iker López, Mariscal de Alba, Andrea, Martínez Vallina, Primitivo, Menal Muñoz, Patricia, Pérez, Laura Mezquita, Olmedo García, María Eugenia, Rombolá, Carlos A, Arregui, Íñigo San Miguel, Somiedo Gutiérrez, María del Valle, Triviño Ramírez, Ana Isabel, Trujillo Reyes, Joan Carles, Vallejo, Carmen, Lozano, Paz Vaquero, Simó, Gonzalo Varela, Zulueta, Javier J

Get full text